Pharmacodynamic evaluation of YKP3089 in epilepsy patients with a photo-induced paroxysmal EEG [electroencephalography]-response: proof of principle.

Trial Profile

Pharmacodynamic evaluation of YKP3089 in epilepsy patients with a photo-induced paroxysmal EEG [electroencephalography]-response: proof of principle.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Dec 2013

At a glance

  • Drugs Cenobamate (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Sponsors SK Life Science
  • Most Recent Events

    • 12 Jun 2012 Actual patient number is 11 as reported by ClincialTrials.gov.
    • 13 Jul 2011 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 13 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top